ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > Gatifloxacinacid
Gatifloxacinacid
Gatifloxacinacid Basic information
- Product Name:
- Gatifloxacinacid
- Synonyms:
-
- Gatifloxacinacid
- 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-, Monohydrochloride (9CI)
- 3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-,hydrochloride (1:1)
- BMS 206584-01 hydrochloride
- Gatifloxacin hydrochloride (AM 1155 hydrochloride
- PD 135432 hydrochloride)
- AM 1155 hydrochloride
- AM 1155 HYDROCHLORIDE;BMS 206584-01 HYDROCHLORIDE;PD 135432 HYDROCHLORIDE
- CAS:
- 121577-32-0
- MF:
- C19H22FN3O4.ClH
- MW:
- 411.859
- Mol File:
- 121577-32-0.mol
More
Less
Gatifloxacinacid Chemical Properties
- storage temp.
- under inert gas (nitrogen or Argon) at 2-8°C
- solubility
- Soluble in DMSO
- form
- Powder
- color
- White to off-white
More
Less
Gatifloxacinacid Usage And Synthesis
Biological Activity
Gatifloxacin hydrochloride (AM-1155 hydrochloride) is a potent fluoroquinolone antibiotic with broad-spectrum antimicrobial activity.
in vivo
Gatifloxacin hydrochloride (subcutaneous injection; 100 mg/kg; 3 times a day; 30 days) significantly decreases the number of lesions in mouse footpad with Nocardia brasiliensis .
< p>Animal Model: | Female BALB/c mice with Nocardia brasiliensis in the right hind footpad |
Dosage: | 100 mg/kg |
Administration: | Subcutaneous injection; 3 times a day; 30 days |
Result: | Reduced the production of lesions in mice. |
target
Topoisomerase II 36.7 μM () |
GatifloxacinacidSupplier
ShangHai Caerulum Pharma Discovery Co., Ltd.
- Tel
- 18149758185 18149758185
- sales-cpd@caerulumpharma.com
Bide Pharmatech Ltd.
- Tel
- 400-164-7117 13681763483
- product02@bidepharm.com
LETOPHARM LIMITED
- Tel
- +86-21-5821 5861
- sales@letopharm.com
Chizhou Kailong Import and Export Trade Co., Ltd.
- Tel
- xg01_gj@163.com
BOC Sciences
- Tel
- 16314854226
- info@bocsci.com